Bover J - Search Results

1

Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait?

Bover J, Ureña-Torres P, Mateu S, DaSilva I, Gràcia S, Sánchez-Baya M, Arana C, Fayos L, Guirado L, Cozzolino M. Bover J, et al. Clin Kidney J. 2020 Jan 25;13(4):513-521. doi: 10.1093/ckj/sfz187. eCollection 2020 Aug. Clin Kidney J. 2020. PMID: 32905295 Free PMC article. Review.

2

Diagnostic procedures and rationale for specific therapies in chronic kidney disease-mineral and bone disorder.

Bover J, Canal C, Marco H, Fernandez-Llama P, Bosch RJ, Ballarín J. Bover J, et al. Contrib Nephrol. 2008;161:222-233. doi: 10.1159/000130690. Contrib Nephrol. 2008. PMID: 18451681 Review.

3

[Tables estimating glomerular filtration rate from plasma creatinine].

Canal C, Pellicer R, Rocha CI, Calero F, Gracia S, Montañés R, Ballarín J, Bover J. Canal C, et al. Among authors: bover j. Nefrologia. 2008;28(3):317-24. Nefrologia. 2008. PMID: 18590499 Free article. Spanish.

4

Update on the treatment of chronic kidney disease-mineral and bone disorder.

Bover J, Farré N, Andrés E, Canal C, Olaya MT, Alonso M, Quílez B, Ballarín J. Bover J, et al. J Ren Care. 2009 Mar;35 Suppl 1:19-27. doi: 10.1111/j.1755-6686.2009.00049.x. J Ren Care. 2009. PMID: 19222727 Review.

5

Role of vitamin D receptor activators in peritoneal dialysis.

Bover J, Lloret MJ, DaSilva I, Furlano M, Díaz M, Herreros A, Cozzolino M, Ballarín J. Bover J, et al. Contrib Nephrol. 2012;178:124-142. doi: 10.1159/000337832. Epub 2012 May 25. Contrib Nephrol. 2012. PMID: 22652728 Review.

6

Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D(2) (Paricalcitol).

Bover J, Dasilva I, Furlano M, Lloret MJ, Diaz-Encarnacion MM, Ballarin J, Cozzolino M. Bover J, et al. Curr Vasc Pharmacol. 2014 Mar;12(2):313-23. doi: 10.2174/15701611113119990028. Curr Vasc Pharmacol. 2014. PMID: 23713879 Review.

7

Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation - safety, efficacy, and patient adherence.

Lloret MJ, Ruiz-García C, Dasilva I, Furlano M, Barreiro Y, Ballarín J, Bover J. Lloret MJ, et al. Among authors: bover j. Patient Prefer Adherence. 2013 Nov 6;7:1147-56. doi: 10.2147/PPA.S31694. Patient Prefer Adherence. 2013. PMID: 24235818 Free PMC article. Review.

8

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; CKD-MBD Working Group of ERA-EDTA. Cozzolino M, et al. Among authors: bover j. Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9. Nephrol Dial Transplant. 2014. PMID: 24516228 Free article.

9

Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders.

Vervloet MG, Massy ZA, Brandenburg VM, Mazzaferro S, Cozzolino M, Ureña-Torres P, Bover J, Goldsmith D; CKD-MBD Working Group of ERA-EDTA. Vervloet MG, et al. Among authors: bover j. Lancet Diabetes Endocrinol. 2014 May;2(5):427-36. doi: 10.1016/S2213-8587(14)70059-2. Lancet Diabetes Endocrinol. 2014. PMID: 24795256 Review.

10

Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation.

Bover J, Cozzolino M. Bover J, et al. Kidney Int Suppl (2011). 2011 Sep;1(4):122-129. doi: 10.1038/kisup.2011.28. Kidney Int Suppl (2011). 2011. PMID: 25018911 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page